ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Soluble urokinase plasminogen activator receptor (suRAR) levels. [Editorial]: underscoring the link between low educational attainment and death among coronary artery disease patients (2024)
Coelho, Otavio R; Santos Filho, Raul Dias dos
Source: European journal of preventive cardiology. Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES, ESCOLARIZAÇÃO, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COELHO, Otavio R e SANTOS FILHO, Raul Dias dos. Soluble urokinase plasminogen activator receptor (suRAR) levels. [Editorial]: underscoring the link between low educational attainment and death among coronary artery disease patients. European journal of preventive cardiology. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://observatorio.fm.usp.br/handle/OPI/76877. Acesso em: 26 jan. 2026. , 2024
APA
Coelho, O. R., & Santos Filho, R. D. dos. (2024). Soluble urokinase plasminogen activator receptor (suRAR) levels. [Editorial]: underscoring the link between low educational attainment and death among coronary artery disease patients. European journal of preventive cardiology. Oxford: Faculdade de Medicina, Universidade de São Paulo. doi:10.1093/eurjpc/zwad346
NLM
Coelho OR, Santos Filho RD dos. Soluble urokinase plasminogen activator receptor (suRAR) levels. [Editorial]: underscoring the link between low educational attainment and death among coronary artery disease patients [Internet]. European journal of preventive cardiology. 2024 ; 31( 5): 519-520.[citado 2026 jan. 26 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76877
Vancouver
Coelho OR, Santos Filho RD dos. Soluble urokinase plasminogen activator receptor (suRAR) levels. [Editorial]: underscoring the link between low educational attainment and death among coronary artery disease patients [Internet]. European journal of preventive cardiology. 2024 ; 31( 5): 519-520.[citado 2026 jan. 26 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76877
Artigo de periodico
Efficacy of dapagliflozin in black versus white patients with heart failure and reduced ejection fraction (2022)
Docherty, Kieran F; Ogunniyi, Modele O; Anand, Inder S; Desai, Akshay S; Diez, Mirta; Howlett, Jonathan G; Nicolau, Jose Carlos ; O'meara, Eileen; Verma, Subodh; Inzucchi, Silvio E
Source: Jacc-heart failure. Unidade: FM
Subjects: INSUFICIÊNCIA CARDÍACA, FÁRMACOS SINTÉTICOS, MORTALIDADE HOSPITALAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOCHERTY, Kieran F et al. Efficacy of dapagliflozin in black versus white patients with heart failure and reduced ejection fraction. Jacc-heart failure, v. 10, n. 1, p. 52-64, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jchf.2021.08.006. Acesso em: 26 jan. 2026.
APA
Docherty, K. F., Ogunniyi, M. O., Anand, I. S., Desai, A. S., Diez, M., Howlett, J. G., et al. (2022). Efficacy of dapagliflozin in black versus white patients with heart failure and reduced ejection fraction. Jacc-heart failure, 10( 1), 52-64. doi:10.1016/j.jchf.2021.08.006
NLM
Docherty KF, Ogunniyi MO, Anand IS, Desai AS, Diez M, Howlett JG, Nicolau JC, O'meara E, Verma S, Inzucchi SE. Efficacy of dapagliflozin in black versus white patients with heart failure and reduced ejection fraction [Internet]. Jacc-heart failure. 2022 ; 10( 1): 52-64.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1016/j.jchf.2021.08.006
Vancouver
Docherty KF, Ogunniyi MO, Anand IS, Desai AS, Diez M, Howlett JG, Nicolau JC, O'meara E, Verma S, Inzucchi SE. Efficacy of dapagliflozin in black versus white patients with heart failure and reduced ejection fraction [Internet]. Jacc-heart failure. 2022 ; 10( 1): 52-64.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1016/j.jchf.2021.08.006
Artigo de periodico
Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract (2018)
Mach, Francois; Santos, Raul D
Source: European heart journal. Unidade: FM
Subjects: INSUFICIÊNCIA RENAL CRÔNICA, MORTALIDADE, DIABETES MELLITUS, ESTUDOS RANDOMIZADOS, PLACEBOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACH, Francois e SANTOS, Raul D. Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. European heart journal, v. 39, n. 27, p. 2526-+, 2018Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehy182. Acesso em: 26 jan. 2026.
APA
Mach, F., & Santos, R. D. (2018). Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. European heart journal, 39( 27), 2526-+. doi:10.1093/eurheartj/ehy182
NLM
Mach F, Santos RD. Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract [Internet]. European heart journal. 2018 ; 39( 27): 2526-+.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1093/eurheartj/ehy182
Vancouver
Mach F, Santos RD. Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract [Internet]. European heart journal. 2018 ; 39( 27): 2526-+.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1093/eurheartj/ehy182

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies